Abbott Says FDA Clears Blood Test to Help Detect Heart Attacks

Date : 09/25/2019 @ 12:52PM
Source : Dow Jones News
Stock : Abbott Laboratories (ABT)
Quote : 85.71  1.59 (1.89%) @ 12:59AM
After Hours
Last Trade
Last $ 85.71 ◊ 0.00 (0.00%)

Abbott Says FDA Clears Blood Test to Help Detect Heart Attacks

Abbott Laboratories (NYSE:ABT)
Historical Stock Chart

2 Months : From Sep 2019 to Nov 2019

Click Here for more Abbott Laboratories Charts.

By Michael Dabaie


Abbott Laboratories (ABT) said its Architect Stat High Sensitivity Troponin-I blood test received clearance from the U.S. Food and Drug Administration.

The technology helps detect heart attacks faster and more accurately than contemporary troponin tests, the company said.

Abbott's blood test, known as High Sensitive Troponin-I in Europe and Asia, has been used throughout hospitals internationally and researched in more than 200 studies for its role in identifying heart disease and cardiac events, Abbott said.

With this clearance, the blood test may be sold in the U.S. for use on Abbott's fully automated Architect analyzer.


Write to Michael Dabaie at


(END) Dow Jones Newswires

September 25, 2019 08:37 ET (12:37 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest ABT Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.